Frugi Biotechnology
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
Frugi Biotechnology was a synthetic biology startup based in Ames, Iowa, founded in 2020 by Iowa State's Nigel Reuel (CEO) and Adam Carr. It developed modular, paper-based diagnostics using synthetic biology to detect pathogens, and proprietary cell-free protein synthesis (CFPS) technology for building and testing antibodies. The company raised $256,000, including grants from the National Science Foundation.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Company founded
Frugi Biotechnology is founded in Ames, Iowa, developing paper-based pathogen diagnostics.
- Grants and development
The company wins NSF grants totaling $256,000 and advances its cell-free protein synthesis platform.
- Acquired by BigHat
On March 28, 2022, BigHat Biosciences acquires Frugi Biotechnology to integrate its CFPS technology into its AI/ML drug discovery platform; the Frugi team joins BigHat.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.